Intercept Pharmaceuticals, Inc.

FMR LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

48,741

Value ($000)

904

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	904	0.0%	48,741	9/30/2023
2023 Q2	8/11/2023	488	0.0%	44,156	6/30/2023
2023 Q1	5/11/2023	591	0.0%	43,976	3/31/2023
2022 Q4	2/13/2023	547	0.0%	44,182	12/31/2022
2022 Q3	11/10/2022	13,035	0.0%	934,378	9/30/2022
2022 Q2	8/12/2022	28,539	0.0%	2,066,506	6/30/2022
2022 Q1	5/13/2022	38,039	0.0%	2,337,992	3/31/2022
2021 Q4	2/14/2022	40,380	0.0%	2,478,822	12/31/2021
2021 Q3	2/14/2022	38,111	0.0%	2,566,430	9/30/2021
2021 Q2	8/13/2021	51,451	0.0%	2,576,472	6/30/2021
2021 Q1	5/14/2021	66,218	0.0%	2,869,051	3/31/2021
2020 Q4	2/8/2021	86,391	0.0%	3,497,611	12/31/2020
2020 Q3	11/13/2020	154,559	0.0%	3,727,918	9/30/2020
2020 Q2	8/24/2020	230,989	0.0%	4,821,305	6/30/2020
2020 Q1	5/14/2020	306,707	0.0%	4,871,464	3/31/2020
2019 Q4	2/7/2020	602,058	0.1%	4,858,446	12/31/2019
2014 Q1	5/15/2014	952,852	0.1%	2,889,269	3/31/2014
2013 Q4	2/13/2014	181,897	0.0%	2,663,980	12/31/2013